medicare coverage of glp-1 drugs Access to GLP-1s for Beneficiaries — A Bridge to Nowhere? | NEJM What Older Adults Should Know

Supplementation of cystine restored mTORC1 signaling and treatment with rapamycin (a specific mTORC1 inhibitor) abolished the induction, providing evidence for the direct role of mTORC1 in the phosphorylation of p70S6K (T389) and S6 (S235/236)

(Pallagst, Wiechmann, and Martinez-Fernandez 2015

Depressed levels of methylcobalamin, vitamin B12, and abnormal Schillings test have been reported in patients receiving octreotide

It is also used for cellular aging support

24,41 Although mononeuropathies are less common than other forms of DN, with a prevalence estimated to be below 1% among diabetes patients, 44,160 and are more frequently observed in older individuals and those with a longer duration of diabetes

Ozempic belongs to a class of drugs called GLP-1 agonists that mimic this hormone